Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expression

Molecular Endocrinology

Volumn 23, Issue 11, 2009, Pages 1776-1786

  Van De Wijngaart, Dennis J ^a   Dubbink, Hendrikus J ^a   Molier, Michel ^a   De Vos, Carola ^a   Trapman, Jan ^a   Jenster, Guido ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BAF60A PROTEIN; BRG1 PROTEIN; FXXLF LIKE PEPTIDE; LEUCINE ZIPPER PROTEIN; MEMBRANE PROTEIN; PROTEIN SWI; PROTEOME; SMALL INTERFERING RNA; SMARCD1 PROTEIN; TMPRSS2 PROTEIN; TRANSCRIPTION FACTOR SNF; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN LNCAP; CHROMATIN ASSEMBLY AND DISASSEMBLY; COMPUTER MODEL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIGAND BINDING; MODULATION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; SCREENING TEST; TRANSCRIPTION REGULATION;

AMINO ACID MOTIFS; CELL LINE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; MALE; MODELS, BIOLOGICAL; PEPTIDES; PROSTATIC NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANDROGEN; RNA, SMALL INTERFERING; SERINE ENDOPEPTIDASES; TRANSCRIPTION FACTORS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 70350464310     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0280     Document Type: Article

References (69)

1. Lee DK, Chang C 2003 Endocrine mechanisms of disease: expression and degradation of androgen receptor: mechanism and clinical implication. J Clin Endocrinol Metab 88:4043-4054 (Pubitemid 37153696)
2. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS 1995 Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:271-321
3. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schü tz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
4. Bain DL, Heneghan AF, Connaghan-Jones KD, Miura MT 2007 Nuclear receptor structure: implications for function. Annu Rev Physiol 69:201-220 (Pubitemid 46457641)
5. Narlikar GJ, Fan HY, Kingston RE 2002 Cooperation between complexes that regulate chromatin structure and transcription. Cell 108:475-487
6. Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM 2007 Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer 120:719-733 (Pubitemid 46175390)
7. Heinlein CA, Chang C 2002 Androgen receptor (AR) coregulators: an overview. Endocr Rev 23:175-200
8. Louie MC, Yang HQ, Ma AH, Xu W, Zou JX, Kung HJ, Chen HW 2003 Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc Natl Acad Sci USA 100:2226-2230 (Pubitemid 36297481)
9. Shang Y, Myers M, Brown M 2002 Formation of the androgen receptor transcription complex. Mol Cell 9:601-610 (Pubitemid 34273790)
10. Verrijdt G, Haelens A, Claessens F 2003 Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression. Mol Genet Metab 78:175-185 (Pubitemid 36335810)
11. Wang Q, Carroll JS, Brown M 2005 Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell 19:631-642 (Pubitemid 41219439)
12. Lee DY, Teyssier C, Strahl BD, Stallcup MR 2005 Role of protein methylation in regulation of transcription. Endocr Rev 26:147-170 (Pubitemid 40503468)
13. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1997 Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198 (Pubitemid 27400603)
14. Stallcup MR, Kim JH, Teyssier C, Lee YH, Ma H, Chen D 2003 The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators. J Steroid Biochem Mol Biol 85:139-145 (Pubitemid 37011092)
15. Wang H, Huang ZQ, Xia L, Feng Q, Erdjument-Bromage H, Strahl BD, Briggs SD, Allis CD, Wong J, Tempst P, Zhang Y 2001 Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293:853-857 (Pubitemid 32743973)
16. Huang ZQ, Li J, Sachs LM, Cole PA, Wong J 2003 A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription. EMBO J 22:2146-2155
17. Marshall TW, Link KA, Petre-Draviam CE, Knudsen KE 2003 Differential requirement of SWI/SNF for androgen receptor activity. J Biol Chem 278:30605-30613 (Pubitemid 36994565)
18. Vijayvargia R, May MS, Fondell JD 2007 A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression. Cancer Res 67:4034-4041 (Pubitemid 46815048)
19. Wang Q, Sharma D, Ren Y, Fondell JD 2002 A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression. J Biol Chem 277:42852-42858 (Pubitemid 35285661)
20. He B, Gampe Jr RT, Kole AJ, Hnat AT, Stanley TB, An G, Stewart EL, Kalman RI, Minges JT, Wilson EM 2004 Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. Mol Cell 16:425-438 (Pubitemid 39504796)
21. Hur E, Pfaff SJ, Payne ES, Grøn H, Buehrer BM, Fletterick RJ 2004 Recognition and accommodation at the androgen receptor coactivator binding interface. PLoS Biol 2:E274 (Pubitemid 39245241)
22. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR 1998 Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev 12: 3343-3356 (Pubitemid 28520983)
23. Ding XF, Anderson CM, Ma H, Hong H, Uht RM, Kushner PJ, Stallcup MR 1998 Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol Endocrinol 12:302-313 (Pubitemid 30658245)
24. Dubbink HJ, Hersmus R, Pike AC, Molier M, Brinkmann AO, Jenster G, Trapman J 2006 Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping. Mol Endocrinol 20:1742-1755 (Pubitemid 44148081)
25. Dubbink HJ, Hersmus R, Verma CS, van der Korput HA, Berrevoets CA, van Tol J, Ziel-van der Made AC, Brinkmann AO, Pike AC, Trapman J 2004 Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor. Mol Endocrinol 18:2132-2150 (Pubitemid 39215246)
26. Hall JM, Chang CY, McDonnell DP 2000 Development of peptide antagonists that target estrogen receptor β-coactivator interactions. Mol Endocrinol 14:2010-2023 (Pubitemid 32063031)
27. He B, Minges JT, Lee LW, Wilson EM 2002 The FXXLF motif mediates androgen receptor-specific interactions with coregulators. J Biol Chem 277:10226-10235 (Pubitemid 34968137)
28. Hu YC, Yeh S, Yeh SD, Sampson ER, Huang J, Li P, Hsu CL, Ting HJ, Lin HK, Wang L, Kim E, Ni J, Chang C 2004 Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. J Biol Chem 279:33438-33446 (Pubitemid 39062993)
29. McInerney EM, Rose DW, Flynn SE, Westin S, Mullen TM, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK, Rosenfeld MG 1998 Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev 12:3357-3368 (Pubitemid 28520984)
30. Wang L, Hsu CL, Ni J, Wang PH, Yeh S, Keng P, Chang C 2004 Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells. Mol Cell Biol 24:2202-2213 (Pubitemid 38248957)
31. 2-terminal interaction with the ligand binding domain of the androgen receptor. J Biol Chem 275:22986-22994
32. Steketee K, Berrevoets CA, Dubbink HJ, Doesburg P, Hersmus R, Brinkmann AO, Trapman J 2002 Amino acids 3-13 and amino acids in and flanking the 23FxxLF27 motif modulate the interaction between the N-terminal and ligand-binding domain of the androgen receptor. Eur J Biochem 269:5780-5791 (Pubitemid 35425576)
33. Askew EB, Gampe Jr RT, Stanley TB, Faggart JL, Wilson EM 2007 Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone. J Biol Chem 282:25801-25816 (Pubitemid 47372778)
34. Callewaert L, Verrijdt G, Christiaens V, Haelens A, Claessens F 2003 Dual function of an amino-terminal amphipatic helix in androgen receptor-mediated transactivation through specific and nonspecific response elements. J Biol Chem 278:8212-8218 (Pubitemid 36800564)
35. 2- and COOH-terminal interaction inhibits p160 coactivator recruitment by activation function 2. J Biol Chem 276:42293-42301
36. 2- and COOH-terminal interaction. J Biol Chem 277:25631-25639
37. van Royen ME, Cunha SM, Brink MC, Mattern KA, Nigg AL, Dubbink HJ, Verschure PJ, Trapman J, Houtsmuller AB 2007 Compartmentalization of androgen receptor protein-protein interactions in living cells. J Cell Biol 177:63-72 (Pubitemid 46588402)
38. Chang CY, Abdo J, Hartney T, McDonnell DP 2005 Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display. Mol Endocrinol 19:2478-2490 (Pubitemid 41362662)
39. van de Wijngaart DJ, van Royen ME, Hersmus R, Pike AC, Houtsmuller AB, Jenster G, Trapman J, Dubbink HJ 2006 Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain. J Biol Chem 281:19407-19416 (Pubitemid 44035446)
40. Giniger E, Ptashne M 1987 Transcription in yeast activated by a putative amphipathic α-helix linked to a DNA binding unit. Nature 330:670-672 (Pubitemid 18005586)
41. Chang C, Norris JD, Grøn H, Paige LA, Hamilton PT, Kenan DJ, Fowlkes D, McDonnell DP 1999 Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors α and β. Mol Cell Biol 19:8226-8239 (Pubitemid 30414017)
42. He B, Wilson EM 2003 Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs. Mol Cell Biol 23:2135-2150 (Pubitemid 36278822)
43. Hsu CL, Chen YL, Yeh S, Ting HJ, Hu YC, Lin H, Wang X, Chang C 2003 The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs. J Biol Chem 278:23691-23698 (Pubitemid 36830192)
44. Kelly KF, Daniel JM 2006 POZ for effect: POZ-ZF transcription factors in cancer and development. Trends Cell Biol 16:578-587 (Pubitemid 44636217)
45. Phelan ML, Sif S, Narlikar GJ, Kingston RE 1999 Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 3:247-253 (Pubitemid 29292625)
46. Lemon B, Inouye C, King DS, Tjian R 2001 Selectivity of chromatin- remodelling cofactors for ligand-activated transcription. Nature 414:924-928 (Pubitemid 34024745)
47. Nie Z, Xue Y, Yang D, Zhou S, Deroo BJ, Archer TK, Wang W 2000 Aspecificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol 20:8879-8888 (Pubitemid 32248734)
48. Wang W, Côté J, Xue Y, Zhou S, Khavari PA, Biggar SR, Muchardt C, Kalpana GV, Goff SP, Yaniv M, Workman JL, Crabtree GR 1996 Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J 15:5370-5382 (Pubitemid 26336219)
49. Wang W, Xue Y, Zhou S, Kuo A, Cairns BR, Crabtree GR 1996 Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev 10:2117-2130 (Pubitemid 26303868)
50. Yan Z, Cui K, Murray DM, Ling C, Xue Y, Gerstein A, Parsons R, Zhao K, Wang W 2005 PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. Genes Dev 19:1662-1667 (Pubitemid 41058360)
51. Belandia B, Orford RL, Hurst HC, Parker MG 2002 Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. EMBO J 21:4094-4103 (Pubitemid 34857441)
52. Dilworth FJ, Fromental-Ramain C, Yamamoto K, Chambon P 2000 ATP-driven chromatin remodeling activity and histone acetyltransferases act sequentially during transactivation by RAR/RXR in vitro. Mol Cell 6:1049-1058
53. Fryer CJ, Archer TK 1998 Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 393:88-91
54. Ichinose H, Garnier JM, Chambon P, Losson R 1997 Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2. Gene 188:95-100 (Pubitemid 27140007)
55. Klokk TI, Kurys P, Elbi C, Nagaich AK, Hendarwanto A, Slagsvold T, Chang CY, Hager GL, Saatcioglu F 2007 Ligand-specific dynamics of the androgen receptor at its response element in living cells. Mol Cell Biol 27:1823-1843 (Pubitemid 46310046)
56. Link KA, Burd CJ, Williams E, Marshall T, Rosson G, Henry E, Weissman B, Knudsen KE 2005 BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF. Mol Cell Biol 25:2200-2215 (Pubitemid 40354619)
57. DiRenzo J, Shang Y, Phelan M, Sif S, Myers M, Kingston R, Brown M 2000 BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol 20:7541-7549 (Pubitemid 30736878)
58. Hsiao PW, Fryer CJ, Trotter KW, Wang W, Archer TK 2003 BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation. Mol Cell Biol 23:6210-6220 (Pubitemid 37013098)
59. Debril MB, Gelman L, Fayard E, Annicotte JS, Rocchi S, Auwerx J 2004 Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit. J Biol Chem 279: 16677-16686 (Pubitemid 38509370)
60. Nomoto K, Nakazato S, Kazahari K, Ono M 1997 Gene structure of rat BAF60b, a component of mammalian SW1/SNF complexes, and its physical linkage to the growth hormone gene and transcription factor SUG/proteasome p45 gene. Gene 202:157-165 (Pubitemid 27523717)
61. Lickert H, Takeuchi JK, Von Both I, Walls JR, McAuliffe F, Adamson SL, Henkelman RM, Wrana JL, Rossant J, Bruneau BG 2004 Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 432:107-112 (Pubitemid 39490836)
62. Takeuchi JK, Lickert H, Bisgrove BW, Sun X, Yamamoto M, Chawengsaksophak K, Hamada H, Yost HJ, Rossant J, Bruneau BG 2007 Baf60c is a nuclear Notch signaling component required for the establishment of left-right asymmetry. Proc Natl Acad Sci USA 104:846-851 (Pubitemid 46154699)
63. Flajollet S, Lefebvre B, Cudejko C, Staels B, Lefebvre P 2007 The core component of the mammalian SWI/SNF complex SMARCD3/ BAF60c is a coactivator for the nuclear retinoic acid receptor. Mol Cell Endocrinol 270:23-32 (Pubitemid 46670547)
64. Koszewski NJ, Henry KW, Lubert EJ, Gravatte H, Noonan DJ 2003 Use of a modified yeast one-hybrid screen to identify BAF60a interactions with the vitamin D receptor heterodimer. J Steroid Biochem Mol Biol 87:223-231 (Pubitemid 38036956)
65. Hermans KG, van Marion R, van Dekken H, Jenster G, van Weerden WM, Trapman J 2006 TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer. Cancer Res 66:10658-10663 (Pubitemid 44876959)
66. Tomlins SA, Mehra R, Rhodes DR, Smith LR, Roulston D, Helgeson BE, Cao X, Wei JT, Rubin MA, Shah RB, Chinnaiyan AM 2006 TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res 66:3396-3400
67. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM 2005 Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644-648 (Pubitemid 41528150)
68. Cleutjens KB, van Eekelen CC, van der Korput HA, Brinkmann AO, Trapman J 1996 Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem 271:6379-6388 (Pubitemid 26095448)
69. Cleutjens KB, van der Korput HA, van Eekelen CC, van Rooij HC, Faber PW, Trapman J 1997 An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol Endocrinol 11:148-161 (Pubitemid 27057428)